|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-10
|
$461,172
|
$230,586
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$159,088
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$1,680
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$4,130
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$5,157
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
$176,138
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
|
1R37CA226969-01
|
$355,706
|
$117,383
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$45,901
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$1,362
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$757
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
$362,725
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
MIC-1 and its functional partners in prostate cancer racial disparity
|
5U01CA185148-04
|
$312,080
|
$102,986
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA022453-36S1
|
$131,250
|
$3,938
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA022453-36S2
|
$351,933
|
$10,558
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA022453-36S3
|
$89,993
|
$2,700
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA022453-36S4
|
$127,646
|
$3,829
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Administrative Supplement to Cancer Center Support Grant to Support Acquisition and Annotation of Biospecimens
|
3P30CA022453-36S5
|
$46,200
|
$1,386
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA022453-36
|
$2,562,428
|
$76,873
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-42S1
|
$59,783
|
$1,196
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Hsp60 regulation of apoptosis in prostate cancer
|
3R01CA160685-04S1
|
$68,720
|
$20,616
|
CHANDRA, DHYAN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy
|
5R21CA215985-02
|
$165,000
|
$165,000
|
CHANG, KAREN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeted Nanotherapy for Pancreatic Cancer
|
5R01CA210192-03
|
$347,700
|
$173,850
|
CHAUHAN, SUBHASH
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Crosstalk between the ER Stress Response and Mitochondrial Fatty Acid Oxidation in MYC-driven Breast Cancer
|
1R37CA228304-01
|
$362,569
|
$119,648
|
CHEN, XI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Precision nanotherapeutics for cancer treatment
|
5R01CA207584-02
|
$381,621
|
$381,621
|
CHENG, JIANJUN
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Fred & Pamela Buffett Cancer Center Support Grant
|
5P30CA036727-32
|
$2,075,035
|
$83,001
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Role of Lipocalin 2 in Pancreatic Cancer
|
1R01CA223204-01A1
|
$356,850
|
$107,055
|
CRUZ-MONSERRATE, ZOBEIDA
|
OHIO STATE UNIVERSITY
|
|
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
|
1P01CA217797-01A1
|
$1,939,848
|
$174,586
|
CULLEN, JOSEPH
|
UNIVERSITY OF IOWA
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
$8,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S3
|
$125,000
|
$5,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
$90,649
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$729
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$2,005
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$2,340
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$25,740
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
ZIA SC 010098
|
$638,195
|
$31,910
|
Dahut, William
|
CCR (NCI)
|
|
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
|
1R01CA219637-01A1
|
$281,441
|
$140,721
|
DAMAJ, M IMAD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross
|
1R01CA221260-01A1
|
$442,176
|
$442,176
|
DAMAJ, M IMAD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
|
5R01CA182435-04
|
$344,269
|
$344,269
|
DATTA, KAUSTUBH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Integrated Training in Cancer Model Systems
|
5T32CA009156-43
|
$793,807
|
$79,381
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-44S1
|
$60,000
|
$600
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-44S2
|
$171,085
|
$1,711
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-44S3
|
$150,571
|
$1,506
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-44
|
$5,755,389
|
$57,554
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN
|
5R01CA200263-03
|
$479,883
|
$479,883
|
DOUGHERTY, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
|
5P01CA210961-02
|
$2,124,555
|
$254,947
|
ESSERMAN, LAURA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$406
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$62,685
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Total relevant funding to Taxol for this search: $24,488,349
|